Press Releases April 23, 2026 08:30 AM

ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call

ICU Medical schedules first quarter 2026 earnings release and conference call for May 7, 2026.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
ICUI

ICU Medical, a Nasdaq-listed leader in medical infusion products, announced the date and time for its first quarter 2026 earnings release and conference call. The earnings will be published on May 7, during which management will discuss the financial results and operational updates. Investors and analysts will have access to the call via phone and webcast.

ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
ICUI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • ICU Medical will release Q1 2026 earnings on May 7, 2026 at 4:00 p.m. ET.
  • A conference call and webcast will follow at 4:30 p.m. ET for management to discuss results.
  • ICU Medical specializes in infusion systems and critical care products across hospital and home care settings, emphasizing innovation and quality.

SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference call.

The Company will release its first quarter 2026 results on Thursday, May 7, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 7, 2026. The call can be accessed at 1-800-343-4136, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.

CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.


Risks

  • Earnings results may not meet market expectations, potentially impacting investor sentiment in the healthcare equipment sector.
  • No specific guidance or preliminary financial results disclosed ahead of the release, introducing uncertainty for stakeholders.
  • Market or regulatory changes affecting hospital and home healthcare demand could influence ICU Medical’s performance post-earnings.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026